Table 4 Proportion of eye responding to CXL in each study
Reference/country | Proportion of eyes improved with CXL | IC 95% |
|---|---|---|
Makdoumi et al. (2010)/Sweden [25] | 6/7 | 0.85 (0.48 to 0.97) |
Makdoumi et al. (2011)/Sweden [24] | 15/16 | 0.93 (0.7 to 0.98) |
Morén (2008)/Sweden [26] | 1/1 | 1 (0.2 to 1) |
Iseli et al. (2008)/Switzerland [27] | 4/5 | 0.8 (0.37 to 0.96) |
Micelli Ferrari et al. (2009)/Italy [28] | 1/1 | 1 (0.2 to 1) |
Khan et al. (2011)/Maryland [29] | 3/3 | 1 (0.43 to 1) |
Anwar et al. (2011)/Saudi Arabia [23] | 1/2 | 0.5 (0.09 to 0.9) |
Price et al. (2012)/USA [34] | 34/40 | 0.85 (07 to 0.92) |
Panda et al. (2012)/India [35] | 7/7 | 1 (0.6 to 1) |
Sorkhabi et al. (2013)/Iran [36] | 8/10 | 0.8 (0.49 to 0.94) |
Müller et al. (2012)/Switzerland [37] | 4/6 | 0.6 (0.3 to 0.9) |
Skaat et al. (2011)/Israel [38] | 5/6 | 0.8 (0.43 to 0.96) |
Total studies | 89/104 | 0.85 (0.77 to 0.91) |